Family Medicine · Jacksonville, FL
NPI
1861506644
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
11513 N Main St
Jacksonville, FL, 32218
Phone (904) 751-6200
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
3,790 services
Medicare patients, 2024
412
Average age 79
Drug cost, 2024
$1.4M
15,095 prescriptions
Company payments, 2025
$947
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zhi J Yu was code 99308 (snf e&m), 2,126 times for 317 patients. In total Zhi J Yu billed 3,790 services in 51 codes, and Medicare paid $245K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 2,126 | 317 | $55.67 | $118K |
| 99309 SNF E&M | Facility | 906 | 303 | $80.61 | $73K |
| 99306 SNF E&M | Facility | 122 | 110 | $141.00 | $17K |
| 99214 Office E&M - Established | Office | 93 | 39 | $86.39 | $8,034 |
| 99305 SNF E&M | Facility | 81 | 77 | $103.43 | $8,378 |
| 36415 Venipuncture Blood Collection | Office | 58 | 34 | $8.65 | $502 |
| 99310 SNF E&M | Facility | 49 | 43 | $118.53 | $5,808 |
| 80053 Clinical Chemistry | Office | 36 | 26 | $10.35 | $373 |
| 83036 Blood Count | Office | 30 | 20 | $9.52 | $286 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 29 | 29 | $17.96 | $521 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 29 | 29 | $125.61 | $3,643 |
| 85025 Blood Count | Office | 26 | 24 | $7.61 | $198 |
| 99497 Care Management/Coordination | Office | 25 | 25 | $79.29 | $1,982 |
| 84443 Clinical Chemistry | Office | 23 | 19 | $16.46 | $379 |
| 80061 Clinical Chemistry | Office | 23 | 19 | $13.12 | $302 |
By year: 2022 $281K for 4,670 services; 2023 $236K for 3,702 services; 2024 $245K for 3,790 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 58 | 34 | $8.65 | $502 |
| 80053 Clinical Chemistry | 36 | 26 | $10.35 | $373 |
| 83036 Blood Count | 30 | 20 | $9.52 | $286 |
| 85025 Blood Count | 26 | 24 | $7.61 | $198 |
| 84443 Clinical Chemistry | 23 | 19 | $16.46 | $379 |
| 80061 Clinical Chemistry | 23 | 19 | $13.12 | $302 |
| 82570 Clinical Chemistry | 12 | 11 | $5.08 | $60.96 |
| 82043 Clinical Chemistry | 12 | 11 | $5.66 | $67.92 |
| 84153 Clinical Chemistry | 11 | 11 | $18.02 | $198 |
Medicare prescription drug claims, 2024
In 2024, the drug Zhi J Yu prescribed most often to Medicare patients was Atorvastatin Calcium, with 894 prescriptions and refills. In total Zhi J Yu wrote 15,095 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 894 | 1,067 | 170 | $17K |
| Amlodipine Besylate Generic | 607 | 767 | 121 | $7,519 |
| Levothyroxine Sodium Generic | 530 | 642 | 92 | $7,667 |
| Eliquis Apixaban | 476 | 497 | 49 | $160K |
| Gabapentin Generic | 467 | 492 | 74 | $11K |
| Lisinopril Generic | 321 | 422 | 58 | $4,854 |
| Ondansetron Hcl Generic | 313 | 313 | 47 | $5,082 |
| Furosemide Generic | 299 | 343 | 62 | $2,575 |
| Metoprolol Tartrate Generic | 282 | 321 | 57 | $3,250 |
| Tamsulosin Hcl Generic | 253 | 322 | 47 | $5,120 |
| Metformin Hcl Generic | 246 | 339 | 46 | $3,031 |
| Xarelto Rivaroxaban | 243 | 243 | 16 | $66K |
| Potassium Chloride Generic | 238 | 243 | 36 | $5,395 |
| Sertraline Hcl Generic | 235 | 255 | 42 | $4,006 |
| Carvedilol Generic | 221 | 265 | 45 | $3,303 |
Brand drugs: 2,597 claims; generic drugs: 12,462 claims; opioid claims: 384.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zhi J Yu $947 ($947 in general payments such as food, travel and fees) from 20 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $314.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $314 |
| Abbott Laboratories ABT | 4 | $78.62 |
| Lundbeck LLC | 4 | $74.13 |
| Lilly USA, LLC LLY | 3 | $50.14 |
| Novo Nordisk Inc NVO | 3 | $48.79 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $44.07 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $42.77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $38.66 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $36.19 |
| Pfizer Inc. PFE | 2 | $33.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.